New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs
Posted Today Scientists at the National Institute of Standards and Technology (NIST) have developed the first U.S. standard for measuring the radioactivity of actinium-225, a radioactive isotope that drug companies are using to develop a new class of anticancer drugs. Actinium-225 and some other radioactive elements that emit alpha rays can be transformed into cancer-fighting missiles […]
New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs Read More »
